Upsher-Smith Laboratories Inc has made a recommended offer for the entire issued and to be issued share capital of Proximagen Group (PRX). The offer values the entire issued ordinary share capital of PRX at approximately £223 million.
Value: $267 million
Announced: June 13 2012
|Parties involved||Legal advisers|
|Upsher-Smith Laboratories Inc||Skadden Arps Slate Meagher & Flom LLP|
|Proximagen Group||Pinsent Masons , Reed Smith LLP|